B
Brickell Biotech Inc
F:VCC2
Brickell Biotech Inc
F:VCC2
Price:
0.1344
EUR
30.61%
Market Closed
Market Cap:
€16m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Brickell Biotech Inc
F:VCC2
|
US |
|
L
|
LSI Software SA
WSE:LSI
|
PL |
|
And Factory Inc
TSE:7035
|
JP |
|
R
|
Revive Therapeutics Ltd
CNSX:RVV
|
CA |
|
Lakshmi Mills Company Ltd
BSE:502958
|
IN |
Income Statement
Earnings Waterfall
Brickell Biotech Inc
Brickell Biotech Inc
Income Statement
Brickell Biotech Inc
Brickell Biotech Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
2
N/A
|
0
-78%
|
7
+1 619%
|
|
| Operating Income | ||||
| Operating Expenses |
(23)
|
(41)
|
(28)
|
|
| Selling, General & Administrative |
(12)
|
(12)
|
(14)
|
|
| Research & Development |
(11)
|
(28)
|
(14)
|
|
| Operating Income |
(21)
N/A
|
(40)
-92%
|
(22)
+46%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
|
| Pre-Tax Income |
(21)
N/A
|
(39)
-89%
|
(21)
+47%
|
|
| Net Income | ||||
| Income from Continuing Operations |
(21)
|
(39)
|
(21)
|
|
| Net Income (Common) |
(21)
N/A
|
(39)
-89%
|
(21)
+47%
|
|
| EPS (Diluted) |
-38.39
N/A
|
-22.12
+42%
|
-7.51
+66%
|
|
Switch to:
Switch to:
See Also
Discover More
